Biology Reference
In-Depth Information
106. Kim YK, Suh I-B, Kim H, Han C-S, Lim C-S, Choi S-H, et al. The plasma levels of
IL-12 in schizophrenia, major depression and bipolar mania: effects of psychotropic
drugs. Mol Psychiatry 2002;10:1107-14.
107. Cremona S, Goujon E, Kelley KW, Dantzer R, Parnet P. Brain type I but not type II
IL-1 receptors mediate the effects of IL-1 on behavior in mice. Am J Physiol
1998;274:R735-40.
108. Neveu JP, Castanon N. Is there evidence for an effect of antidepressant drugs on immune
function. In: Dantzer R, Wollmann EE, Yirmiya R, editors. Cytokines, stress and depres-
sion. New York: Plenum Press; 1999. p. 267-82.
109. Kubera M, Kenis G, Bosmans E, Scharpe S, Maes M. Effects of serotonin and serotoner-
gic agonists and antagonists on the production of interferon-gamma and interleukin-10.
Neuropsychopharmacology 2000;23:89-98.
110. Kubera M, Symbirtsev A, Basta-Kaim A, Borycz J, Roman A, Papp M, et al. Effect of
chronic treatment with imipramine on interleukin 1 and interleukin 2 production by sple-
nocytes obtained from rats subjected to a chronic mild stress model of depression. Pol J
Pharmacol 1996;48:503-6.
111. Kubera M, Holan V, Basta-Kaim A, Roman A, Borycz J, Shani J. Effect of desip-
ramine on immunological parameters in mice, and their reversal by stress. Int J
Immunopharmacol 1998;20:429-38.
112. Kubera M, Maes M, Holan V, Basta-Kaim A, Roman A, Shani J. Prolonged desipramine
treatment increases the production of interleukin-10, an anti-inflammatory cytokine, in
C57BL/6 mice subjected to the chronic mild stress model of depression. J Affect Disord
2001;63:171-78.
113. Suzuki E, Shintani F, Kanba S, Asai M, Nakaki T. Induction of interleukin-1 beta and
interleukin-1 receptor antagonist mRNA by chronic treatment with various psychotrop-
ics in widespread area of rat brain. Neurosci Lett 1996;215:201-4.
114. Tucker P, Ruwe WD, Masters B, Parker DE, Hossain A, Trautman RP, et al.
Neuroimmune and cortisol changes in selective serotonin reuptake inhibitor and placebo
treatment of chronic posttraumatic stress disorder. Biol Psychiatry 2004;56:121-28.
115. Kubera M, Skowron-Cendrzak A, Mazur-Kolecka B, Bubak-Satora M, Basta-Kaim A,
Laskowska-Bozsek H, et al. Stress-induced changes in muscarinic and -adrenergic
binding sites on rat thymocytes and lymphocytes. J Neuroimmunol 1992;37:229-35.
116. Jaffre F, Callebert J, Sarre A, Etienne N, Nebigil CG, Launay JM, et al. Involvement of
the serotonin 5-HT2B receptor in cardiac hypertrophy linked to sympathetic stimulation:
control of interleukin-6, interleukin 1beta, and tumor necrosis factor-alpha cytokine pro-
duction by ventricular fibroblasts. Circulation 2004;110:969-74.
117. Maes M, Song C, Lin AH, Bonaccorso S, Kenis G, Jongh RD, et al. Negative immuno-
regulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of
interleukin-10 secretion. Neuropsychopharmacology 1999;20:370-79.
118. Kubera M, Lin AH, Kenis G, Bosmans E, Van Bockstaele D, Maes M. Anti-
inflammatory effects of antidepressants through suppression of the interferon-/interleu-
kin 10 production ratio. J Clin Psychopharmacol 2001;21:199-206.
119. Sternberg EM. Neural-immune interaction in health and disease. J Clin Invest
1997;100:2641-47.
120. Bonnet M, Lespinats G, Burtin C. Histamine and serotonin suppression of lymphocyte
response to phytohemagglutinin and antigen. Cell Immunol 1984;83:280-91.
121. Song C, Leonard BE. Serotonin reuptake inhibitors reverse the impairments in behav-
iour, neurotransmitter and immune function in the olfactory bulbectomised rat. Hum
Psychopharmacol 1994;9:135-46.
